Correlation Between Ligand Pharms and Berkshire Hathaway

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ligand Pharms and Berkshire Hathaway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ligand Pharms and Berkshire Hathaway into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ligand Pharms Glucagon and Berkshire Hathaway, you can compare the effects of market volatilities on Ligand Pharms and Berkshire Hathaway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ligand Pharms with a short position of Berkshire Hathaway. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ligand Pharms and Berkshire Hathaway.

Diversification Opportunities for Ligand Pharms and Berkshire Hathaway

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Ligand and Berkshire is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ligand Pharms Glucagon and Berkshire Hathaway in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Berkshire Hathaway and Ligand Pharms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ligand Pharms Glucagon are associated (or correlated) with Berkshire Hathaway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Berkshire Hathaway has no effect on the direction of Ligand Pharms i.e., Ligand Pharms and Berkshire Hathaway go up and down completely randomly.

Pair Corralation between Ligand Pharms and Berkshire Hathaway

If you would invest  0.70  in Ligand Pharms Glucagon on January 21, 2024 and sell it today you would lose (0.55) from holding Ligand Pharms Glucagon or give up 78.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Ligand Pharms Glucagon  vs.  Berkshire Hathaway

 Performance 
       Timeline  
Ligand Pharms Glucagon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ligand Pharms Glucagon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Berkshire Hathaway 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Berkshire Hathaway has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward-looking signals, Berkshire Hathaway is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ligand Pharms and Berkshire Hathaway Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ligand Pharms and Berkshire Hathaway

The main advantage of trading using opposite Ligand Pharms and Berkshire Hathaway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ligand Pharms position performs unexpectedly, Berkshire Hathaway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Berkshire Hathaway will offset losses from the drop in Berkshire Hathaway's long position.
The idea behind Ligand Pharms Glucagon and Berkshire Hathaway pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data